Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99Tc-MDP intra-articular injection for knee osteoarthritis
ChiCTR2500114977Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Dec 2025
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of technetium-99m-methylene diphosphonate in knee osteoarthritis (OA), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Lequesne score and VAS score. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
technetium-99m-methylene diphosphonate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500114977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114977.